GAIA
Built for the life sciences.
Why GAIA?
At a time when financial resources for life science early and growth-stage companies are increasingly constrained, a strong product is only part of the equation for fundraising and commercial growth. Success depends on the demonstrated alignment of your entire go-to-market strategy: from product-market fit and launch readiness to sales enablement, demand generation, channel strategy, and beyond. When these dimensions are misaligned, the consequences compound quickly.
That is why we created GAIA. It evaluates your full GTM landscape across 13 critical dimensions, identifies gaps, risks, and misalignment, and delivers a prioritized roadmap so you can focus resources on the areas with the greatest commercial impact.
What GAIA Delivers
Key Findings & Executive Summary
GAIA generates a clear, prioritized summary across 13 dimensions of your GTM program. Built from the ground up for the life sciences, GAIA highlights the most important findings, identifies contradictions, surfaces critical risks, and provides a focused view of strengths, gaps, and next steps so you can sharpen decisions, and focus on the actions that matter most.
AI-Augmented Strategic Analysis
Beyond comparing your entire GTM program against a 310-parameter rules engine designed specifically for the life sciences, GAIA deploys 3 independent AI agents in parallel across 6 strategic dimensions, uncovering blind spots, contradictions, and untapped opportunities before they become costly market mistakes.
Prioritized Action Plan & Rationale
GAIA doesn't just identify problems. It tells you what to fix first and why. The action plan is constructed from your data, organized by urgency, and tied directly to the specific findings that drove each recommendation, so your team can act with clarity, align resources faster, and prioritize the changes with the greatest commercial impact.
Who Is GAIA For?
INVESTORS & BOARDS
Evaluate go-to-market risk across all commercial dimensions before committing capital. GAIA helps you assess whether a company's GTM strategy is comprehensive, aligned, and execution-ready.
CEOs & FOUNDERS
Pressure-test your full go-to-market strategy before major launch, scale, or fundraising decisions. GAIA surfaces hidden gaps across sales, marketing, channel, and operations so you can act with confidence.
CCOs
Align every GTM dimension before execution begins. GAIA evaluates commercial readiness, sales enablement, demand generation, and channel strategy together so nothing falls through the cracks.
PRODUCT LEADERS
Connect product readiness to the broader GTM picture. GAIA helps you understand how product-market fit, launch strategy, and commercial infrastructure work together to support market entry.
Comprehensive Insights. Same Day Results.
Step 1: Complete Intake Form
Share your GTM strategy across all 13 dimensions
Step 2: Export and Submit Your Results
GAIA processes your data through our 310-rule analysis engine
Step 3: Receive Full GTM Analysis Same Day
Get your comprehensive report with actionable insights
How GAIA Works
13-Dimension GTM Assessment
GAIA evaluates your go-to-market strategy across 13 critical dimensions: product-market fit, commercial readiness, launch strategy, sales enablement, demand generation, channel partners, customer success, brand strategy, market development, GTM operations, risks and milestones, and internal and external assets.
310-Rule Analysis Engine
GAIA processes your inputs against 310 analytical rules purpose-built for life sciences commercialization. These rules catch misalignment, contradictions, and dependencies across all 13 GTM dimensions so you can be confident that your entire commercial strategy tells a coherent story.
AI-Augmented Strategic Review
Beyond the rules engine, GAIA runs multiple independent AI review passes that analyze cross-dimension consistency, strategic gaps, data quality, and narrative coherence so you can identify blind spots that rules alone might miss.
Scored Section Analysis
Each of GAIA's 13 dimensions receives a scored assessment with status classification: Critical, Underperforming, Nominal, or Overperforming. You get a clear, visual picture of where your GTM strategy is strong and where it needs attention.
Prioritized Action Plan
GAIA generates a phased action plan organized by urgency and impact. Every recommendation is tied to specific findings so you can walk into your next leadership meeting with a clear roadmap rather than a list of open questions.
Self-Contained Deliverables
GAIA produces an interactive HTML report with the 3D sphere visualization, tabbed navigation, expandable finding details, and a consolidated executive summary. Share it with your board, investors, or commercial team.
Frequently Asked Questions
What is GAIA and what does it assess?
GAIA is a comprehensive go-to-market assessment platform built for the life sciences. It evaluates your entire GTM strategy across 13 critical dimensions, including product-market fit, commercial readiness, launch strategy, sales enablement, demand generation, channel partners, customer success, brand strategy, market development, GTM operations, risks and milestones, and internal and external assets. The result is a scored, prioritized view of your full commercial landscape.
Who is GAIA for?
GAIA is designed for life sciences founders, CEOs, commercial leaders, product leaders, and investors who need a comprehensive view of their go-to-market readiness before committing to launch, scale, or fundraising decisions.
How is GAIA different from PRIYA?
While PRIYA focuses specifically on 2 dimensions (product-market fit and commercial readiness), GAIA provides a broader, more comprehensive assessment across 13 GTM dimensions. GAIA covers the full go-to-market landscape including sales enablement, demand generation, channel strategy, customer success, brand strategy, market development, and GTM operations. Think of PRIYA as the focused diagnostic and GAIA as the full commercial health check.
How much time does a GAIA assessment save?
A comprehensive GTM assessment that would typically require 4 to 6 weeks of cross-functional work can be compressed into same day delivery with GAIA, saving hundreds of hours of stakeholder interviews, manual analysis, and strategy reconciliation. GAIA eliminates the need to coordinate across dozens of stakeholders and synthesize findings from scratch.
What does GAIA's 310-rule engine actually do?
GAIA's rules engine is a deterministic analysis layer purpose-built for life sciences commercialization. It evaluates your inputs against 310 rules that catch contradictions, gaps, and cross-dimension dependencies. For example, it checks whether your pricing model is consistent with your target customer profile, whether your sales enablement supports your channel strategy, and whether your launch timeline aligns with your regulatory pathway.
Can GAIA take disparate files as source material?
Yes. GAIA is designed to ingest multiple file types, including PowerPoint, Word, Excel, PDFs, and text files. It reviews those materials together, surfaces gaps and inconsistencies, and ensures your data, assumptions, and messaging are aligned across all 13 GTM dimensions.
How is GAIA different from a management consulting firm?
Traditional consulting firms often involve long timelines, large teams, and high-cost engagements, and findings can vary significantly between firms or even between teams at the same firm. GAIA is built on a standardized, repeatable rules engine that has been validated with repeated runs, very much like a diagnostic assay, to produce consistent results. This means companies can return to GAIA over time to reassess their GTM readiness against a consistent baseline, giving them a reliable measure of progress rather than a subjective snapshot. It provides the rigor of a major consulting engagement without the multi-month timelines and six-figure price tags.
Can't I just use ChatGPT, Claude, Grok, or Gemini?
Unlike general AI tools, which produce inconsistent answers and lack domain-specific structure, GAIA delivers a comprehensive GTM diagnostic purpose-built for life sciences. It applies a proprietary 310-rule methodology, reviews your materials for cross-dimension alignment and strategic coherence, identifies gaps, contradictions, and risks, and turns those findings into a scored assessment with prioritized next steps.
Does GAIA just point out problems?
No. GAIA provides a scored assessment, strategic narrative, and prioritized action plan. Every finding is classified by severity, tied to specific dimensions, and accompanied by recommended next steps so you know exactly what to do and in what order.
Can GAIA help with investor readiness?
Yes. GAIA helps identify the GTM gaps and risks that investors and boards will challenge. It provides a comprehensive, evidence-based view of commercial readiness that strengthens investor confidence and board presentations.
What are the 13 dimensions GAIA evaluates?
GAIA evaluates: Product-Market Fit, Commercial Readiness, Product Readiness, Launch Strategy, Sales Enablement, Demand Generation, Channel Partners, Customer Success, Brand Strategy, Market Development, GTM Operations, Risks & Milestones, and Internal & External Assets. Each dimension is scored independently and also assessed for cross-dimension alignment.
How do I get started?
Click the "Register for Access" button below and we will get in touch shortly. GAIA is currently onboarding select life sciences companies.
Ready to Assess Your Full Go-To-Market Strategy?
REGISTER FOR ACCESSProven Commercial Experience
